Last reviewed · How we verify
NCT03765307: BATA
Bronchial Ablation for Treatment of Asthma (BATA) Trial
NA trial testing SyMap Bronchial Ablation System in Asthma in 160 participants. Participants enrolled and being followed up; not accepting new ones.
15 August 2024
Quick facts
| Lead sponsor | SyMap Medical (Suzhou), Ltd. |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 160 |
| Start date | 18 June 2019 |
| Primary completion | 15 August 2024 |
| Estimated completion | 31 December 2028 |
| Sites | 15 locations across China |
Drugs / interventions tested
- SyMap Bronchial Ablation System
- Boston Scientific Alair System
Conditions studied
- Asthma — all drugs for Asthma →
Sponsor
SyMap Medical (Suzhou), Ltd.
Who can join
Adults 18 to 65, any sex, with Asthma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the safety and efficacy of a bronchial radiofrequency ablation system (SyMap Medical (Suzhou) Ltd) in a population of subjects with severe asthma who are still symptomatic despite being managed on high-dose Inhaled Corticosteroids (ICS) and Long-Acting β2-adrenergic Agonists (LABA).
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Bronchial thermoplasty reduces ventilation heterogeneity measured by phase-resolved functional lung magnetic resonance imaging in severe asthma.
Foo CT, Langton D, Donovan GM, Thompson BR, et al · · 2025 · cited 1× · PMID 41121109 · DOI 10.1186/s12931-025-03372-w -
Bronchial thermoplasty for severe asthma: Systematic review and meta-analysis of benefits and harms.
Rayner DG, Chu AWL, Cox G, Ologundudu L, et al · · 2026 · PMID 41907855 · DOI 10.1016/j.jacig.2026.100678
Verify or expand the search:
- PubMed search for NCT03765307
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Asthma
Currently open trials in the same condition.
- NCT07525375 — A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t · Phase 2 · recruiting
- NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
- NCT07556159 — A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice · recruiting
- NCT07282886 — VENTURI (VENTilation Using Respiratory Imaging) · Phase 2 · recruiting
- NCT07433569 — A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Differ · Phase 1 · recruiting
Other SyMap Medical (Suzhou), Ltd. trials
Trials by the same sponsor.
- NCT07336433 — SMART-IC-Pilot Study · NA · not yet recruiting
- NCT02761811 — Sympathetic Mapping/ Ablation of Renal Nerves Trial · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03765307 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by SyMap Medical (Suzhou), Ltd.
- Last refreshed: 2 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03765307.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing